Previously published observations have demonstrated that murine antibody with specificity for phosphorylcholine (PC) binds to a variety of PC-containing polysaccharides and to human 13-lipoprotein. In this investigation it was found that monoclonal anti-PC antibody binds not only to human ,I-lipoprotein, but also to ,8-lipoprotein from the serum of all vertebrate species examined. ,8-Lipoprotein from mouse reacted with autologous antibody; therefore, this antibody must be an autoantibody. This raises the question whether PC antibodies may exert unwanted effects after having been passively transferred or induced by PC-containing antigens, e.g., C-polysaccharide from pneumococci.
Antibodies with specificity for phosphorylcholine (PC) have been the subject of many publications during the last 15 years. A restricted immune response to PC is found in humans (7), rabbits (25) , and mice (12) . The three antibody families with PC specificity found in the mouse (8) have been carefully studied, and even three-dimensional structural analysis of the antigen-combining site of these antibodies has been carried out (1, 16, 19) .
Because C-polysaccharide (C-Ps), the cell wall antigen common to all capsular types of Streptococcus pneumoniae, contains PC (24), anti-PC antibodies might protect against pneumococcal infections. Recent animal studies support this theory (3-6, 15, 23, 26-28) .
Anti-PC antibodies are also useful for detection of PCcontaining antigens (20, 21) . However, preliminary investigations in my laboratory showed that monoclonal anti-PC antibody could not be used for detection of PC-containing antigens in serum or spinal fluid because of nonspecific reactions.
Leon and Young (13) have reported that murine myeloma protein specific for PC residues also binds to human Ilipoprotein. This observation has apparently been overlooked in the more recent literature. I have studied the binding of monoclonal anti-PC antibody to ,B-lipoprotein from various animal species. The results presented confirm and extend the observations of Leon and Young.
MATERIALS AND METHODS
Normal sera. Sera from human, horse, pig, mouse, rat, hamster, chinchilla, rabbit, hen, and goose were collected at this institute. Serum from rainbow trout was received from the Laboratory of Aquatic Pathobiology, The Royal Veterinary and Agricultural University, Copenhagen.
Antisera. Antisera to human serum (no. A206) and to human P-lipoprotein (no. A060) were obtained from DAKOPATTS, Glostrup, Denmark. Monoclonal anti-PC antibody. Mouse-mouse hybridomas were made basically by the standard procedure, and the monoclonal anti-PC antibody, designated HAS, was prepared and characterized as described previously (20) . Ascitic fluid antibody was partially purified by ammonium sulfate precipitation and ion exchange chromatography (DEAESephadex A-50; Pharmacia, Uppsala, Sweden). The protein concentration in the final product was 2 mg/ml.
Immunoelectrophoresis. HSA agarose (1%; Litex, Glostrup, Denmark) gels and Tris-veronal buffer (pH 8.6) with an ionic strength of 0.02 were used for immunoelectrophoresis (11) .
Crossed immunoelectrophoresis of 10 ,ul of human serum, diluted 1:9 with saline, was run in first-dimension gels for about 1.5 h at 10 V/cm (15°C) until the bovine serum albumin marker (stained with bromphenol blue) had moved 5 cm.
i Second-dimension gels were run perpendicularly to the first-dimension gels overnight at 2 V/cm (15°C). The upper gels contained antibody to human serum or humanlipoprotein (10 pA/cm2 of gel area). The intermediate gels contained either HAS or saline (75 pA/cm2 of gel). Due to the relatively large volumes added to the intermediate gels, 2% agarose was used for their preparation.
Rocket-line-immunoelectrophoresis was carried out as described previously (21) . The upper gel contained HAS (10 i.4'cm2 of gel), and 20 pul of serum (or saline) was applied to wells in the intermediate gel. The lower gel contained C-Ps (4 p[tg/cm2 of gel) prepared as described elsewhere (21) . Electrophoresis was done overnight at 2 V/cm (15°C).
RESULTS
The crossed immunoelectrophoresis with polyspecific antibody to human serum in the upper gel made the individual proteins of the serum sample visible in a semiquantitative manner (Fig. 1A) . After addition of monoclonal antiphosphorylcholine antibody (HAS) to the intermediate gel, one protein precipitated at a lower position (Fig. 1B) , demonstrating binding of HAS to this protein. None of the other serum proteins were affected by HAS (Fig. 1A and B) . When monospecific antibody to human ,B-lipoprotein was used in the upper gel, only this protein was precipitated (Fig. 1C) . After addition of HAS to the intermediate gel, the ,Blipoprotein precipitated at a lower position, demonstrating that this is the protein that binds to the HAS (Fig. 1D) . In rocket-line-immunoelectrophoresis a line was formed when the C-Ps from the lower gel was precipitated by the HAS in the upper gel (Fig. 2, control well 12 ). Due to a change in the antigen-antibody equilibrium, the line was lifted above wells that contained an antigen that bound the HAS antibody. Figure 2 shows that all sera tested contained such an antigen. HAS therefore probably binds specifically to 3-lipoprotein from the sera of all vertebrate species. Remarkably, the ANTIPHOSPHORYLCHOLINE ANTIBODY BINDS TO antibody produced in mice also bound to ,-lipoprotein from mouse serum (Fig. 2, well 10) , i.e., this antibody is an autoantibody.
DISCUSSION
Preliminary attempts at developing an assay based on monoclonal anti-PC antibody for the detection of C-Ps in samples of serum or spinal fluid failed because of nonspecific reactions with these samples. By immunoelectrophoresis it was demonstrated that a serum protein, the P-lipoprotein, was bound by the monoclonal anti-PC antibody (Fig. 1C and  D) . Other serum proteins were not affected by this antibody (Fig. 1A and B) .
Sera from 10 different animal species and humans all contained various amounts of anti-PC antibody-binding proteins. Even a serum protein from the mouse itself reacted with the autologous antibody (Fig. 2, well 10) , demonstrating that this antibody must be an autoantibody.
All plasma lipoproteins are known to contain PC residues. However, only the ,B-lipoprotein (low-density and very low density lipoprotein) seems to expose the PC residues on the surface, making binding of substances with specificity for this determinant possible (18) . C-Reactive protein is an acute-phase plasma protein with the property of binding to PC-containing substances. It has been demonstrated that C-reactive protein from human, rat, and rabbit binds to autologous ,-lipoproteins (9, 17, 18) . Leon and Young (13) demonstrated that six different murine myeloma proteins with PC specificity all reacted with human P-lipoprotein, and others have reported that some human myeloma proteins also bind to human ,-lipoprotein (2, 14, 22) . In fact, the PC antigen-antibody system is unique. The monoclonal HAS antibody reacted not only with six different PC-containing pneumococcal capsular polysaccharides and C-Ps, as described previously (20) , but also with P-lipoprotein, and therefore in a sense lacks antigen specificity. These observations should be kept in mind when considering the possible protectivity of anti-PC antibody against pneumococcal infections (3-6, 15, 23, 26, 27) , because nothing is known about what happens when anti-PC antibodies appear as autoantibodies. Perhaps PC-containing antigens may induce unwanted immune responses against ,-lipoprotein, leading to a condition similar to autoimmune hyperlipidemia, as has been described for myeloma patients with M proteins specific for the PC determinant (2, 22) . Infants develop antibody to PC in response to pneumococcal colonization and infection (10) . Do these antibodies also act as autoantibodies? 
